Contracts › 75F40121C00137
75F40121C00137: Area of Need: Drug Development for Pediatric Cancers Has Historically Lagged Far Behind Adult Cancers, and Mostly Relied on a ?Trickle Down? Effect From Adult Oncology. Furthermore, There Is Often a Gap of 5-10 Years Between Adult and Pediatric App
Awarded to The Children's Hospital of Philadelphia by Food and Drug Administration (FDA).
$1.0Mobligated
$1.0Mpotential value
07 September 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40121C00137 |
|---|---|
| Awardee | The Children's Hospital of Philadelphia |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN11 Health R&D Services; Health Care Services; Basic Research |
| Place of performance | MD |
| Offers received | 1 |
| Period of performance | 08 September 2021 to 07 September 2026 |
| Potential end | 07 September 2026 |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 06 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record